| 000 | 01054 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512013636.0 | ||
| 264 | 0 | _c19900305 | |
| 008 | 199003s 0 0 eng d | ||
| 022 | _a0091-7435 | ||
| 024 | 7 |
_a10.1016/0091-7435(89)90040-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aByar, D P | |
| 245 | 0 | 0 |
_aSome statistical considerations for design of cancer prevention trials. _h[electronic resource] |
| 260 |
_bPreventive medicine _cSep 1989 |
||
| 300 |
_a688-99 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aFactor Analysis, Statistical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xepidemiology |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aResearch Design _xstatistics & numerical data |
| 773 | 0 |
_tPreventive medicine _gvol. 18 _gno. 5 _gp. 688-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-7435(89)90040-6 _zAvailable from publisher's website |
| 999 |
_c2700044 _d2700044 |
||